Verve Therapeutics, Inc. short interest in 2024
In 2024, Verve Therapeutics, Inc.'s disclosed short interest ran from 14.78% of shares outstanding on 12 Jan 2024 to 16.79% on 31 Dec 2024, a change of +2.01 percentage points. The year's high was 22.28% on 31 May 2024 and its low 14.78% on 12 Jan 2024, averaging 18.69% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.50 days on 28 Mar 2024. Full history: Verve Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2024 in figures
- Start of year
- 14.78% (12 Jan 2024)
- End of year
- 16.79% (31 Dec 2024)
- Change
- +2.01 pp
- High
- 22.28% (31 May 2024)
- Low
- 14.78% (12 Jan 2024)
- Average
- 18.69%
- Highest days to cover
- 21.50 (28 Mar 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 14.78% | 11.78 | |
| 31 Jan 2024 | 14.80% | 13.75 | |
| 15 Feb 2024 | 15.05% | 11.01 | |
| 29 Feb 2024 | 14.97% | 10.32 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 16.87% | 10.05 | |
| 28 Mar 2024 | 18.37% | 21.50 | |
| 15 Apr 2024 | 18.77% | 7.30 | |
| 30 Apr 2024 | 19.78% | 16.66 | |
| 15 May 2024 | 20.95% | 12.79 | 10-Q filed, results (8-K) |
| 31 May 2024 | 22.28% | 11.71 | |
| 14 Jun 2024 | 21.01% | 15.88 | |
| 28 Jun 2024 | 18.08% | 8.38 | |
| 15 Jul 2024 | 18.34% | 11.78 | |
| 31 Jul 2024 | 19.33% | 15.20 | |
| 15 Aug 2024 | 19.20% | 11.60 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 19.29% | 8.88 | |
| 13 Sep 2024 | 18.75% | 12.54 | |
| 30 Sep 2024 | 19.97% | 12.73 | |
| 15 Oct 2024 | 20.61% | 16.00 | |
| 31 Oct 2024 | 20.35% | 16.82 | |
| 15 Nov 2024 | 20.17% | 10.18 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 21.11% | 11.37 | |
| 13 Dec 2024 | 18.87% | 8.89 | |
| 31 Dec 2024 | 16.79% | 9.26 |
See also: Verve Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.